Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes

Inclusion Criteria: 1. Adults, 20 years of age or older at the time of informed consent, of either gender, diagnosed with bilateral cataracts; 2. Able to comprehend and sign a statement of informed consent; 3. Willing and able to complete all required postoperative visits; 4. Calculated lens power within the available range; 5. Planned cataract removal by phacoemulsification; 6. Potential postoperative BCDVA of 0.5 decimal or better in both eyes; 7. Subject with preoperative astigmatism \< 1.0 D 8. Clear intraocular media other than cataract in both eyes; 9. The subject must be able to undergo second eye surgery within 30 days of the first eye surgery. \[Justification for the inclusion criteria\] 1. and 5: Cataract extraction is the indication of the clinical study. 2. and 3: One of GCP requirements 4: Essential condition for implant of the investigational lens. 6, 7, 8 and 9: Conditions to minimize the potential non-IOL factors which may affect the visual acuity data Exclusion Criteria: \[Exclusion Criteria Prior to Surgery\] The patient who meets any criteria specified in the following 1) through 22). 1. Irregular corneal aberration that affects postoperative visual function as demonstrated by corneal topography; 2. Inflammation or edema (swelling) of the cornea affecting post-operative visual acuity; 3. Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal disorders) that are predicted to cause future acuity losses to a level worse than 0.5 decimal for BCDVA; 4. Subjects who may be expected to require ocular surgery (other than blepharo-surgery, laser surgery of fundus and YAG capsulotomy) during the study; 5. Previous refractive surgery; 6. Amblyopia; 7. Clinically severe corneal dystrophy (eg., epithelial, stromal, or endothelial dystrophy), keratitis, keratoconjunctivitis, keratouveitis, keratopathy, or kerectasia; 8. Diabetic retinopathy; 9. Extremely shallow anterior chamber, not due to swollen cataract; 10. Microphthalmos; 11. Current or previous retinal detachment; 12. Previous corneal transplant; 13. Recurrent severe anterior or posterior segment inflammation of unknown etiology; 14. Rubella or traumatic cataract; 15. Iris neovascularization; 16. Glaucoma or ocular hypertension; 17. Aniridia; 18. Optic nerve atrophy; 19. Planned clear lensectomy (no lens opacity) 20. Pregnancy, lactating or possible pregnant; 21. Participation in any clinical study (drug or device) within 3 months prior to participating this study, planned participation another clinical study during this study, or currently participating in another study. 22. Disqualified by the investigator or the sub-investigator because of physical or ophthalmic diseases. \[Exclusion Criteria During Surgery\] The patient who meets any criteria specified in the following 1) through 7). 1. Mechanical or surgical manipulation required to enlarge the pupil; 2. Excessive iris mobility; 3. Significant vitreous loss; 4. Significant anterior chamber hyphema; 5. Uncontrollable intraocular pressure; 6. Zonular or capsular rupture or tear; 7. IOL could not be fixed in the lens capsule;